PATENT CLAIM ANALYSIS

Application Number: 15966613
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "254070"]

Abstract:
The present invention concerns methods for treating a proliferation disorder, such as prostate cancer, basal cell carcinoma, lung cancer, and other cancers, using an inhibitor of the Hedgehog pathway (HhP); and methods for monitoring subjects undergoing such treatments based on biomarkers and other criteria predictive of efficacy.

Claim (Index 5):
The method of  claim 3 , wherein the SUBA\u00ae formulation is a SUBA-CAP formulation.

Metadata:
- Claim Count in Document: 89.0
- Percentile: 91.0
- Lexical Diversity: 1.27273
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15420283', '15966844', '15420247', '14173588', '11990729']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8297549071347048
- 35 USC 102 Novelty (BERT): 0.5998820955357586
- Combined Prediction Score: 0.8067676259748102
- Mean Citation Score: 570.6201560000002
- Max Citation Score: 657.5403
- Similarity Product: 430.32046860115526

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test